You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Melbourne breast cancer trial to test Optiscan imaging device
- 2. Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
- 3. Global research trends in tryptophan metabolism and cancer: a bibliometric and visualization analysis (2005–2024)
- 4. Hsa_circ_0001859 promotes NSCLC progression through the miRNA-101-3p/MMP1 axis
- 5. Case Report: Surgical androgen deprivation therapy for prostate cancer in a patient with concurrent scrotal paget's disease
- 6. Peptone Hosts In-Person Advisory Meeting With Leading Experts in Oncology, Drug Development and Medicinal Chemistry to Advance Small Molecule IDP-Targeted Treatment Solutions
- 7. Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study
- 8. Study reveals mechanisms behind common mutation and prostate cancer
- 9. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 10. Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies
Last updated at 22:38 GMT
Hot News Makers
Health/Pharma Companies
-
157094.64
-
48825.60
-
26415.44
-
15017.11
-
13853.14
-
11314.34
-
10513.31
-
9559.19
-
8626.07
-
7848.84
Drugs, Treatments, Trials
-
15960.01
-
5852.01
-
5602.10
-
5191.53
-
3996.02
-
3934.38
-
2837.71
-
2541.83
-
2541.34
-
2267.85
Last updated at 22:10 GMT
